Paul G. Abrams
Direktor/Vorstandsmitglied bei Geneius Biotechnology, Inc.
Profil
Paul G.
Abrams is currently the Executive Director at Geneius Biotechnology, Inc. He was previously the President & Chief Executive Officer at Poniard Pharmaceuticals, Inc. from 1990 to 2001.
He also served as the President & Chief Executive Officer at CEPTYR, Inc.
Aktive Positionen von Paul G. Abrams
Unternehmen | Position | Beginn |
---|---|---|
Geneius Biotechnology, Inc.
Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Paul G. Abrams
Unternehmen | Position | Ende |
---|---|---|
PONIARD PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 31.07.2001 |
CEPTYR, Inc.
CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PONIARD PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
CEPTYR, Inc.
CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA. | Health Technology |
Geneius Biotechnology, Inc.
Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA. | Commercial Services |